Identification of a novel mutation and genotype-phenotype relationship in MEGF10 myopathy.

Gene mutation Literature review Muscle CT Muscle biopsy Myofibrillar myopathy Respiratory failure

Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
05 2022
Historique:
received: 01 12 2021
revised: 17 01 2022
accepted: 21 01 2022
pubmed: 5 4 2022
medline: 18 5 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

Mutations in MEGF10 are associated with early-onset myopathy, areflexia, respiratory distress, and dysphagia (EMARDD). Recently, a mild variant phenotype of EMARDD has been reported in patients with multiple minicores in the myofibers. However, some reported patients had no clear cores. We present a patient who had progressive weakness since his 30 s and then developed severe respiratory failure at the age of 66 years and found that he had a novel mutation, p.G739R, in MEGF10. He had no clear core in the biopsied muscle. We summarize the clinical and genetic characteristics of the current and reported patients with MEGF10 and statistically evaluate the genotype-phenotype correlation. Results show that patients with missense mutations in at least one allele had significantly later onset than those with biallelic truncation mutations.

Identifiants

pubmed: 35370044
pii: S0960-8966(22)00025-6
doi: 10.1016/j.nmd.2022.01.009
pii:
doi:

Substances chimiques

Membrane Proteins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-440

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Kanako Fujii (K)

Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.

Makito Hirano (M)

Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan. Electronic address: mahirano-neuro@umin.ac.jp.

Atsushi Terayama (A)

Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.

Rino Inada (R)

Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.

Yoshihiko Saito (Y)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.

Ichizo Nishino (I)

Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.

Yoshitaka Nagai (Y)

Department of Neurology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH